Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - DEPRECIATION & AMORTIZATION
Depreciation & Amortization PRLD - Prelude Therapeutics Incorporated
1.17 M
LAST VALUE
13.03%
2 YEAR CAGR
50.98%
5 YEAR CAGR
0.00%
10 YEAR CAGR